Mark Labrecque

Mark Labrecque is a Senior Scientist I in Translational Sciences at Revolution Medicines since January 2022, previously serving as a Scientist II in the same department. Prior experience includes a Senior Fellow position at the University of Washington, where Mark conducted translational prostate cancer research and led a team on a Rapid Autopsy Program. Earlier roles at Simon Fraser University included Lecturer, Graduate Research Assistant, and Teaching Assistant, where Mark contributed to course development and delivery in health sciences. Mark's research experience also encompasses work at BC Cancer on breast cancer models, with a Ph.D. in Health Sciences from Simon Fraser University and a BSc in Cell Biology and Genetics from The University of British Columbia.